- Section 16 Genetics of cardiovascular diseases
- Section 17 Congenital heart disease in children and adults
- Section 18 Prevention in cardiovascular disease and rehabilitation
- Section 19 Diabetes mellitus and metabolic syndrome
- Section 20 Heart and the brain
- Section 21 Cardiovascular problems in chronic kidney disease
- Section 22 Erectile dysfunction
- Section 23 Lung disease
- Section 24 Gastrointestinal disease
- Section 25 Rheumatoid arthritis and the heart
- Section 26 Rheumatic heart disease
- Section 27 Cardio-oncology
- Section 28 HIV
- Section 29 Acute coronary syndromes
- Section 30 Takotsubo syndrome
- Section 31 Chronic ischaemic heart disease
- Section 32 Myocardial disease
- Section 33 Pericardial disease
- Section 34 Tumours of the heart
- Section 35 Valvular heart disease
- Section 36 Infective endocarditis
- Section 37 Heart failure
- Section 38 Bradycardia
- Section 39 Syncope
- Section 40 Supraventricular tachycardias
- Section 41 Atrial fibrillation
- Section 42 Ventricular tachycardia
- Section 43 Sudden cardiac death
- Section 44 Systemic hypertension
- Chapter 44.1 Epidemiology and pathophysiology of hypertension
- Chapter 44.2 Blood pressure measurement in hypertension: definition and classification of blood pressure levels
- Chapter 44.3 Target organ damage, cardiovascular disease risk, and clinical evaluation of the hypertensive patient
- Chapter 44.4 Secondary causes of hypertension
- Chapter 44.5 Blood pressure thresholds for treatment and blood pressure treatment targets in hypertension
- Chapter 44.6 Sodium and potassium intake, blood pressure, and cardiovascular prevention
- Chapter 44.7 Drug treatment of hypertension
- Chapter 44.8 Device-based treatment for hypertension
- Chapter 44.9 Hypertension in specific conditions/co-morbidities
- Chapter 44.10 Hypertension in special situations
(p. 2377) Systemic hypertension
Hypertension remains the leading cause of morbidity and mortality worldwide and significantly impacts the risk of all major cardiovascular events, including stroke, sudden cardiac death, coronary heart disease, heart failure, abdominal aortic aneurysm, and peripheral vascular disease. Important advances in our understanding of its pathophysiology contributed to clarifying the complex origins of the disease, involving dysregulation of multiple homeostatic systems influencing not only blood pressure but also the progression of end-organ damage related to hypertension. Growing evidence suggests that the pathophysiology of hypertension results from complex interactions between environmental and genetic factors, resulting in different risks and age of onset of the disease within the general population. This chapter reviews the recent statistics of hypertension with a specific emphasis on its prevalence and temporal trends in Europe. Also, it provides a comprehensive overview of the mechanisms involved in the aetiopathogenesis of hypertension, highlighting their relative importance in different forms of hypertension.
Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.
Please subscribe or login to access full text content.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.
For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.
- Section 16 Genetics of cardiovascular diseases
- Section 17 Congenital heart disease in children and adults
- Section 18 Prevention in cardiovascular disease and rehabilitation
- Section 19 Diabetes mellitus and metabolic syndrome
- Section 20 Heart and the brain
- Section 21 Cardiovascular problems in chronic kidney disease
- Section 22 Erectile dysfunction
- Section 23 Lung disease
- Section 24 Gastrointestinal disease
- Section 25 Rheumatoid arthritis and the heart
- Section 26 Rheumatic heart disease
- Section 27 Cardio-oncology
- Section 28 HIV
- Section 29 Acute coronary syndromes
- Section 30 Takotsubo syndrome
- Section 31 Chronic ischaemic heart disease
- Section 32 Myocardial disease
- Section 33 Pericardial disease
- Section 34 Tumours of the heart
- Section 35 Valvular heart disease
- Section 36 Infective endocarditis
- Section 37 Heart failure
- Section 38 Bradycardia
- Section 39 Syncope
- Section 40 Supraventricular tachycardias
- Section 41 Atrial fibrillation
- Section 42 Ventricular tachycardia
- Section 43 Sudden cardiac death
- Section 44 Systemic hypertension
- Chapter 44.1 Epidemiology and pathophysiology of hypertension
- Chapter 44.2 Blood pressure measurement in hypertension: definition and classification of blood pressure levels
- Chapter 44.3 Target organ damage, cardiovascular disease risk, and clinical evaluation of the hypertensive patient
- Chapter 44.4 Secondary causes of hypertension
- Chapter 44.5 Blood pressure thresholds for treatment and blood pressure treatment targets in hypertension
- Chapter 44.6 Sodium and potassium intake, blood pressure, and cardiovascular prevention
- Chapter 44.7 Drug treatment of hypertension
- Chapter 44.8 Device-based treatment for hypertension
- Chapter 44.9 Hypertension in specific conditions/co-morbidities
- Chapter 44.10 Hypertension in special situations